Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?
- 21 May 2020
- journal article
- letter
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (6)
- https://doi.org/10.1128/aac.00388-20
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Does Pharmacokinetics in the Central Compartment Evidence Routes of Elimination During Continuous Renal Replacement Therapy in Ex Vivo Model?Critical Care Medicine, 2020
- Pharmacokinetics and Dialytic Clearance of Isavuconazole during In Vitro and In Vivo Continuous Renal Replacement TherapyAntimicrobial Agents and Chemotherapy, 2019
- Continuous renal replacement therapy in the treatment of severe hyperkalemia: An in vitro studyThe International Journal of Artificial Organs, 2019
- Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo ModelCritical Care Medicine, 2019
- RE to manuscript ‘In vitro removal of anti-infective agents by a novel cytokine adsorbent system’The International Journal of Artificial Organs, 2019
- Ex vivo Ceftolozane/Tazobactam Clearance during Continuous Renal Replacement TherapyBlood Purification, 2017
- Adsorption of Amikacin, a Significant Mechanism of Elimination by HemofiltrationAntimicrobial Agents and Chemotherapy, 2008
- The Adsorption of Vancomycin by Polyacrylonitrile, Polyamide, and Polysulfone HemofiltersArtificial Organs, 2007
- Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration.1987